Complex evaluation of human monocyte-derived dendritic cells for cancer immunotherapy
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F12%3A00061849" target="_blank" >RIV/00216224:14110/12:00061849 - isvavai.cz</a>
Result on the web
<a href="http://dx.doi.org/10.1111/j.1582-4934.2012.01614.x" target="_blank" >http://dx.doi.org/10.1111/j.1582-4934.2012.01614.x</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1111/j.1582-4934.2012.01614.x" target="_blank" >10.1111/j.1582-4934.2012.01614.x</a>
Alternative languages
Result language
angličtina
Original language name
Complex evaluation of human monocyte-derived dendritic cells for cancer immunotherapy
Original language description
Dendritic cell (DC) immunotherapy is capable of generating tumour-specific immune responses. Different maturation strategies were previously tested to obtain DC capable of anti-cancer responses in vitro, usually with limited clinical benefit. Mutual comparison of currently used maturation strategies and subsequent complex evaluation of DC functions and their stimulatory capacity on T cells was performed in this study to optimize the DC vaccination strategy for further clinical application. DC were generated from monocytes using granulocyte?macrophage colony-stimulating factor (GM-CSF) and interleukin (IL)-4, pulsed with whole tumour cell lysate and then matured with one of five selected maturation strategies or cultured without additional maturation stimulus. DC were characterized with regard to their surface marker expression, cytokine profiles, migratory capacity, allogeneic and autologous T cell stimulatory capacity as well as their specific cytotoxicity against tumour antigens.
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FD - Oncology and haematology
OECD FORD branch
—
Result continuities
Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2012
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Journal of Cellular and Molecular Medicine
ISSN
1582-1838
e-ISSN
—
Volume of the periodical
16
Issue of the periodical within the volume
11
Country of publishing house
GB - UNITED KINGDOM
Number of pages
11
Pages from-to
2827-2837
UT code for WoS article
000310555200026
EID of the result in the Scopus database
—